Elena Gargaun et al.
The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
Biomedicines 2021, vol. 9, issue 2
doi: 10.3390/biomedicines9020219